how does glp 1 tirzepatide work Bridging the gap between GLP1-receptor agonists and cardiovascular outcomes: evidence for the role of | Cardiovascular Diabetology How tirzepatide works for weight

p = 0.55

Elevated insulin and insulin resistance appears to be present in some males with AGA

15% Patients lost an average of 15% of their body weight in ~1 year.* *In a 68-week double-blind trial studying once-weekly semaglutide injections (2.4 mg) in 1,961 patients without diabetes and with BMI 30, or BMI 27 with a weight-related condition, the average weight loss was 15%, when paired with diet and exercise changes

FDA labeling says short-term use (a few weeks), though many obesity specialists use it for 12 weeks or longer based on observational evidence

A neurochemical theory of autism

Injectable semaglutide is described as generally well tolerated and less dependent on fasting state